Target type: biologicalprocess
Any process that stops, prevents or reduces the frequency, rate or extent of cellular respiration. [GOC:TermGenie, GOC:yaf, PMID:23150719]
Negative regulation of cellular respiration is a vital biological process that involves the control and modulation of the intricate biochemical reactions responsible for energy production within cells. It ensures that energy production occurs at the appropriate rate and in response to the cell's changing needs. This regulation is crucial for maintaining cellular homeostasis, adapting to environmental fluctuations, and preventing excessive energy expenditure. The process encompasses a complex interplay of various molecular mechanisms, including:
1. **Control of substrate availability:** The availability of fuels like glucose, fatty acids, and amino acids influences the rate of cellular respiration. Enzymes involved in their breakdown and transport can be regulated, affecting substrate delivery to the mitochondria, the powerhouse of the cell.
2. **Regulation of enzyme activity:** The activity of key enzymes involved in the different stages of cellular respiration is tightly controlled. This can involve allosteric regulation by molecules such as ATP, ADP, and NADH, which act as metabolic signals reflecting the cell's energy state. Additionally, covalent modifications like phosphorylation can alter enzyme activity.
3. **Regulation of gene expression:** The expression of genes encoding enzymes involved in cellular respiration can be adjusted in response to cellular needs. This allows cells to modulate the production of specific enzymes, fine-tuning the metabolic pathways involved.
4. **Feedback mechanisms:** Cellular respiration is subject to intricate feedback loops, ensuring that the process responds appropriately to changes in energy demand. For example, high levels of ATP can inhibit certain enzymatic steps in glycolysis and the citric acid cycle, slowing down respiration.
5. **Hormonal control:** Hormones such as insulin, glucagon, and thyroid hormones play significant roles in regulating cellular respiration. They influence the availability of substrates, enzyme activity, and gene expression, ultimately impacting the overall metabolic rate.
6. **Environmental factors:** Cellular respiration is sensitive to changes in environmental conditions, such as temperature, pH, and oxygen availability. These factors can influence the activity of enzymes and the efficiency of energy production.
In summary, negative regulation of cellular respiration is a multifaceted process that involves a complex interplay of molecular mechanisms, ensuring a fine balance between energy production and cellular needs. These regulatory mechanisms ensure that energy production remains optimal under various physiological conditions, contributing to cellular homeostasis and overall organismal health.'
"
Protein | Definition | Taxonomy |
---|---|---|
Heat shock protein 75 kDa, mitochondrial | A heat shock protein 75 kDa, mitochondrial that is encoded in the genome of human. [PRO:DAN] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
adenosine diphosphate | Adenosine Diphosphate: Adenosine 5'-(trihydrogen diphosphate). An adenine nucleotide containing two phosphate groups esterified to the sugar moiety at the 5'-position. | adenosine 5'-phosphate; purine ribonucleoside 5'-diphosphate | fundamental metabolite; human metabolite |
geldanamycin | 1,4-benzoquinones; ansamycin; carbamate ester; organic heterobicyclic compound | antimicrobial agent; antineoplastic agent; antiviral agent; cysteine protease inhibitor; Hsp90 inhibitor | |
tanespimycin | CP 127374: analog of herbimycin A | 1,4-benzoquinones; ansamycin; carbamate ester; organic heterobicyclic compound; secondary amino compound | antineoplastic agent; apoptosis inducer; Hsp90 inhibitor |
9h-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-n-(1-methylethyl)- | 9H-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-N-(1-methylethyl)-: an epichaperome (purine-scaffold) inhibitor; structure in first source | ||
ec 144 | EC 144: structure in first source | ||
cnf 2024 | 2-aminopurines; aromatic ether; organochlorine compound; pyridines | antineoplastic agent; Hsp90 inhibitor | |
snx 2112 | SNX 2112: an orally available small molecule Hsp90 inhibitor; structure in first source | ||
debio 0932 | CUDC 305: an Hsp90 inhibitor with antineoplastic activity; structure in first source | ||
tas-116 | |||
ver 52296 | luminespib : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 5-(2,4-dihydroxy-5-isopropylphenyl)-4-[4-(morpholin-4-ylmethyl)phenyl]-1,2-oxazole-3-carboxylic acid with the amino group of ethylamine. | aromatic amide; isoxazoles; monocarboxylic acid amide; morpholines; resorcinols | angiogenesis inhibitor; antineoplastic agent; Hsp90 inhibitor |
sta 9090 | ring assembly; triazoles |